+44 (0)20 3910 4640 info@symmetron.net
  • 🗨 We’re hiring!
Symmetron
  • Services
  • Therapeutic areas
  • The Team
  • Careers
  • Contact
Select Page

Tocilizumab in methotrexate-naïve rheumatoid arthritis: a cost-utility model for Slovakia

by Symmetron | Jan 21, 2019

Rheumatoid arthritis   Tocilizumab in methotrexate-naïve rheumatoid arthritis: a cost-utility model for Slovakia Value in Health. 2015;18(7):A648 Authors Chang S, Sawyer L, Dejonckheere F, Grichova L, Diamantopoulos A   For more information about health economic...

Recent Comments

    Archives

    Categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Privacy Policy
    © 2019 Symmetron Ltd